Evidence map›Paper›PMID 36504750›Full record

ArticleNanoscale advances2022

Drug delivery with a pH-sensitive star-like dextran-graft polyacrylamide copolymer.

Anna Grebinyk, Svitlana Prylutska, Sergii Grebinyk, Stanislav Ponomarenko, Pavlo Virych, Vasyl Chumachenko, Nataliya Kutsevol, Yuriy Prylutskyy, Uwe Ritter, Marcus Frohme

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Anna GrebinykDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau Hochschulring 1 15745 Wildau Germany mfrohme@th-wildau.de.ORCID https://orcid.org/0000-0002-4651-7908
Svitlana PrylutskaNational University of Life and Environmental Science of Ukraine Heroiv Oborony Str., 15 03041 Kyiv Ukraine.
Sergii GrebinykDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau Hochschulring 1 15745 Wildau Germany mfrohme@th-wildau.de.
Stanislav PonomarenkoTaras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine.
Pavlo VirychTaras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine.
Vasyl ChumachenkoTaras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine.
Nataliya KutsevolTaras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine.
Yuriy PrylutskyyTaras Shevchenko National University of Kyiv Volodymyrska Str., 64 01601 Kyiv Ukraine.
Uwe RitterTechnical University of Ilmenau, Institute of Chemistry and Biotechnology Weimarer Str., 25 98693 Ilmenau Germany.
Marcus FrohmeDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau Hochschulring 1 15745 Wildau Germany mfrohme@th-wildau.de.ORCID https://orcid.org/0000-0001-9063-2682
Taras Shevchenko National University of Kyiv · UATechnical University of Applied Sciences Wildau · DEInstitut Charles Sadron · FRNational University of Life and Environmental Sciences of Ukraine · UATechnische Universität Ilmenau · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of precision cancer medicine relies on novel formulation strategies for targeted drug delivery to increase the therapeutic outcome. Biocompatible polymer nanoparticles, namely dextran-

Identifiers

PMID36504750
PMCPMC9680934
OpenAlexW4311283534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.